The Cancer Control and Outcomes Program is one of three scientific programs in the ECOG-ACRIN Cancer Research Group. This program addresses a broad range of research aims, primarily those that are part of the cancer control continuum, which is widely recognized throughout the research community as including: cancer prevention, early detection, diagnosis and surveillance, treatment, and survivorship.
ECOG-ACRIN’s Cancer Control and Outcomes program aims to significantly reduce the burden of cancer on individual and societal levels by designing and conducting practice-changing clinical trials that span the entire continuum, from prevention through survivorship, in the communities where individuals receive their care. This program also engages in health equity research by studying determinants of disparities in cancer clinical trials, promoting accrual, and addressing the unique needs of younger and older adults diagnosed with cancer. Across the program, there is an emphasis on cancer care delivery research. For more information about the cancer control continuum, visit the NCI website.
Lynne I. Wagner, PhD
Wake Forest University and the Comprehensive Cancer Center of Wake Forest University
Mitchell D. Schnall, MD, PhD
University of Pennsylvania
Drs. Wagner and Schnall are also the co-principle investigators for the ECOG-ACRIN Cancer Research Group’s grant from the National Cancer Institute as a research base in the NCI Community Oncology Research Program (NCORP).
Information to come.
There are five large scientific committees within the Cancer Control and Outcomes Program. Each committee has its own scientific aims and subcommittees.
To promote and ensure scientific interactions with the other two scientific programs—Therapeutic Studies and Biomarker Sciences—individuals with certain expertise serve as liaisons.
|Cancer Control and Outcomes Program|
|Therapeutic Studies Program|
|Biomarker Sciences Program|